| Issue |
Title |
File |
| Vol 21, No 3 (2025) |
Regional experience of administration of lenvatinib and pembrolizumab combination in patients with disseminated renal cell carcinoma |
(Rus)
|
|
Kadyrova D.D., Anzhiganova Y.V., Zukov R.A.
|
| Vol 21, No 3 (2025) |
Immuno-oncological safety and toxicity of 1st line combined therapy in patients with advanced renal cell carcinoma: real world study |
(Rus)
|
|
Volkova M.I., Lyadova M.A., Nersesova Т.A., Kuzmina E.S., Antonova T.G., Tsareva E.V., Stativko O.A., Pokataev I.A.
|
| Vol 21, No 3 (2025) |
The use of remote mentor technology during laparoscopic partial nephrectomy |
(Rus)
|
|
Semeniakin I.V., Gadzhiev N.K., Petrov A.D., Dzhalilov I.B., Derevyanko S.P., Cherepanov А.Е., Bogatov A.V., Izmailov A.A.
|
| Vol 21, No 3 (2025) |
Prognosis improvement in elderly patients with metastatic renal cell carcinoma in the era of systemic therapy and factors affecting survival rates |
(Rus)
|
|
Semenov D.V., Orlova R.V., Shirokorad V.I., Kostritsky S.V.
|
| Vol 21, No 2 (2025) |
Analysis of survival rates and evaluation of prognostic factors in patients with bone metastases of renal cancer |
(Rus)
|
|
Semenov D.V., Orlova R.V., Shirokorad V.I., Kostritsky S.V.
|
| Vol 21, No 2 (2025) |
Assessment of kidney injury during immune-targeted therapy (pembrolizumab + axitinib) in patients with metastatic renal cell carcinoma and solitary kidney |
(Rus)
|
|
Titov K.S., Epifanova M.V., Alimov A.A., Shutov E.V., Nesterova O.Y., Lebedev S.S., Zapirov G.M.
|
| Vol 21, No 2 (2025) |
Efficacy of avelumab and axitinib depending on disease burden in patients with metastatic renal cell carcinoma: a subgroup analysis of the RAVE-Renal trial |
(Rus)
|
|
Chubenko V.A., Baklanova O.V., Kalpinskiy A.S., Safina S.Z., Lebedinets A.A., Petkau V.V., Parsadanova E.L., Anzhiganova Y.V., Novikova O.Y., Bragina V.S., Tkacheva E.V., Shkurat A.O., Gluzman M.I., Zukov R.A., Tsimafeyeu I.V.
|
| Vol 21, No 2 (2025) |
Real-world outcomes of lenvatinib plus pembrolizumab in intermediateand poor-risk metastatic renal cell carcinoma |
(Rus)
|
|
Tsimafeyeu I.V., Sultanbaev A.V., Dubovichenko D.M., Murzalina M.J., Volkov A.A., Orlova R.V., Utyashev I.A., Malina G.D., Gluzman M.I.
|
| Vol 21, No 1 (2025) |
Clinical case of locally advanced renal cell carcinoma with an inferior vena cava tumor thrombus treated with VEGFR-TKI/IO combination pembrolizumab + lenvatinib |
(Rus)
|
|
Orlova R.V., Shkolnik M.I., Gluzman M.I., Bogomolov O.A., Kozlov A.V., Sidorova S.A., Rutkin I.O.
|
| Vol 20, No 3 (2024) |
Metastasectomy in patients with multiple and oligometastases of renal cell carcinoma treated in general clinical practice |
(Rus)
|
|
Semenov D.V., Orlova R.V., Shirokorad V.I., Kostritskiy S.V., Karlova N.A.
|
| Vol 20, No 3 (2024) |
Functional results of partial nephrectomy depending on the use of various intraoperative techniques |
(Rus)
|
|
Seregin A.A., Seregin A.V., Dadasheva A.E., Ibragimov M.A., Mulabaev N.S., Kolontarev K.B., Loran O.B.
|
| Vol 20, No 3 (2024) |
Efficacy of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell carcinoma |
(Rus)
|
|
Volkova M.I., Kalpinskiy A.S., Goncharova О.A., Menshikov К.V., Stativko O.A., Karabina E.V., Dergunov A.S., Polshina N.I., Aleksandrova E.N., Lebedinets A.A., Panov A.K., Sultanbaev A.V., Usynin E.A., Volkonsky M.V., Mikhalyuk V.V., Zukov R.A., Anzhiganova Y.V., Gusniev M.A., Igumnova E.N., Kuzmicheva S.V., Pokataev I.A., Olshanskaya A.S., Pervakova N.I., Parsadanova E.L., Sannikova T.A., Bystrov A.A., Dubovichenko D.M., Mukhitova M.R., Chubenko V.A., Shkret K.A., Gorshenina M.N., Semenov A.V., Davlatova M.K., Kosareva A.E., Lutoshkina O.A., Maslova O.A., Makhnutina M.V., Mishina A.V., Murzalina M.Z., Podyacheva O.A., Kalinin S.A., Mailyan O.A., Safarova A.R., Semenova K.O., Strokova M.A., Urashkina E.Y., Shmygina O.S., Novikova O.Y.
|
| Vol 20, No 2 (2024) |
Effectiveness of modern immunotherapy in combination treatment of patients with renal cancer and bone metastases |
(Rus)
|
|
Kostritskiy S.V., Shirokorad V.I., Semenov D.V., Kalpinskiy A.S., Kononets P.V.
|
| Vol 20, No 2 (2024) |
Lenvatinib and pembrolizumab combination in metastatic renal cell carcinoma: experience of the Republic of Bashkortostan |
(Rus)
|
|
Menshikov K.V., Lipatov D.O., Nasretdinov A.F., Musin S.I., Sultanbaeva N.I., Menshikova I.A., Sultanbaev A.V., Izmaylov A.A., Galimov S.N., Rezyapova A.S.
|
| Vol 20, No 1 (2024) |
Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms |
(Rus)
|
|
Grünwald V., Powles T., Eto M., Kopyltsov E., Rha S.Y., Porta C., Motzer R., Hutson T.E., Méndez-Vidal M.J., Hong S.H., Winquist E., Goh J.C., Maroto P., Buchler T., Takagi T., Burgents J.E., Perini R., He C., Okpara C.E., McKenzie J., Choueiri T.K.
|
| Vol 20, No 1 (2024) |
Nephrometry scoring systems RENAL, PADUA, C-index, SPARE, and ZONAL NePhRO for prediction of partial nephrectomy outcomes |
(Rus)
|
|
Guliev B.G., Povago I.A.
|
| Vol 19, No 4 (2023) |
Functional outcomes of repeat kidney resection in patients with cancer recurrence after nephron-sparing surgeries |
(Rus)
|
|
Zhumabaev N.K., Komarov M.I., Klimov A.V., Matveev V.B., Stilidi I.S.
|
| Vol 19, No 4 (2023) |
Metastasis suppressor kisspeptin (KISS1) in serum of patients with renal cell carcinoma |
(Rus)
|
|
Kushlinskii N.E., Kovaleva O.V., Gershtein E.S., Alferov A.A., Kuzmin Y.B., Bezhanova S.D., Klimanov I.A., Lyubimova N.V., Gratchev A.N., Zybina N.N., Matveev V.B., Stilidi I.S.
|
| Vol 19, No 4 (2023) |
Survival by depth of response and efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma: analysis of the phase 3 randomized CLEAR study |
(Rus)
|
|
Grünwald V., Powles T., Kopyltsov E., Kozlov V., Alonso-Gordoa T., Eto M., Hutson T., Motzer R., Winquist E., Maroto P., Keam B., Procopio G., Wong S., Melichar B., Rolland F., Oya M., Rodriguez-Lopez K., Saito K., McKenzie J., Porta C.
|
| Vol 19, No 4 (2023) |
First experience of using Pembroria® medication in patients with disseminated renal cell carcinoma |
(Rus)
|
|
Shevchuk I.M., Movchan N.D.
|
| Vol 19, No 3 (2023) |
Acute kidney injury and its predictors in surgery of malignant kidney tumors |
(Rus)
|
|
Pozdnyakov K.V., Rakul S.A., Eloev R.A., Lukinov K.A.
|
| Vol 19, No 3 (2023) |
Cytoreductive nephrectomy and its effect on prognosis in patients with disseminated renal cell carcinoma receiving treatment in wide clinical practice |
(Rus)
|
|
Semenov D.V., Orlova R.V., Shirokorad V.I., Kostritskiy S.V., Gluzman M.I., Korneva Y.S.
|
| Vol 19, No 3 (2023) |
Review of the article “Acute kidney injury and its predictors in surgery of malignant kidney tumors” |
(Rus)
|
|
Perlin D.V.
|
| Vol 19, No 2 (2023) |
Characterization and management of adverse reactions from the CLEAR study in advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab |
(Rus)
|
|
Motzer R., George S., Merchan J.R., Hutson T.E., Song X., Perini R.F., Xie R., Bapat U., Puente J.
|
| Vol 19, No 2 (2023) |
Correlation between 3D morphometric characteristics of kidney tumors and their histological structure |
(Rus)
|
|
Fiev D.N., Sirota E.S., Kozlov V.V., Proskura A.V., Shpot E.V., Chernenkiy M.M., Chernenkiy I.M., Puzakov K.B., Azil’gareeva K.R., Ismailov K.M., Butnaru D.V., Kutikov A., Vinarov A.Z.
|
| Vol 19, No 1 (2023) |
The role of obesity in patients with renal cell carcinoma |
(Rus)
|
|
Kravtsov I.B., Solodky V.A., Pavlov A.Y., Dzidzaria A.G., Fastovets S.V., Khoroshevskaya I.V.
|
| Vol 19, No 1 (2023) |
Retroperitoneoscopic access in organ-preserving treatment of renal cell carcinoma |
(Rus)
|
|
Chaykov V.S., Dementyev I.O., Karyakin O.B., Shchukina E.O., Troyanov A.V., Ivanov S.A., Kaprin A.D.
|
| Vol 19, No 1 (2023) |
Efficacy and safety of cabozantinib in metastatic renal cell carcinoma patients: Russian multicenter observational study |
(Rus)
|
|
Volkova M.I., Kalpinskiy A.S., Men'shikov K.V., Gorbuleva L.V., Evsyukova O.I., Meltonyan V.R., Mishugin S.V., Maturov M.R., Ol'shanskaya A.S., Shemetov D.Y., Sannikova T.A., Makhnutina M.V., Filip'eva M.A., Gaysina E.A., Ovchinnikova E.G., Matveev V.B., Alekseev B.Y.
|
| Vol 19, No 1 (2023) |
Robot-assisted repeat resection of recurrent kidney tumors |
(Rus)
|
|
Guliev B.G.
|
| Vol 19, No 1 (2023) |
Review of the article “Retroperitoneoscopic access in organ-preserving treatment of renal cell carcinoma” |
(Rus)
|
|
Perlin D.V.
|
| Vol 18, No 3 (2022) |
Evaluation of quality of life of patients with solitary renal cancer metastases in bones before and after surgical treatment in combination with targeted therapy and without it |
(Rus)
|
|
Kostritskiy S.V., Shirokorad V.I., Alekseev B.Y., Semenov D.V., Kalpinskiy A.S., Korneva Y.S.
|
| Vol 18, No 3 (2022) |
New lenvatinib and pembrolizumab combination for metastatic renal cell carcinoma in 1st line drug treatment: comparative effectiveness and safety |
(Rus)
|
|
Alekseev B.Y., Shevchuk I.M.
|
| Vol 18, No 3 (2022) |
Preventive sutures in nonischemic laparoscopic partial nephrectomy. Description of S.P. Botkin City Clinical Hospital technique |
(Rus)
|
|
Seregin A.A., Seregin A.V., Kolontarev K.B., Seregin I.V., Makhmadaliev A.I., Loran O.B.
|
| Vol 18, No 3 (2022) |
Transperitoneal laparoscopic and robot-assisted resection of anterior and posterior kidney tumors |
(Rus)
|
|
Guliev B.G., Komyakov B.K., Yakubov K.K.
|
| Vol 18, No 3 (2022) |
Review of the article “Transperitoneal laparoscopic and robot-assisted resection of anterior and posterior kidney tumors” |
(Rus)
|
|
Perlin D.V.
|
| Vol 18, No 3 (2022) |
Techniques of surgical hemostasis and sealing after laparoscopic partial nephrectomy |
(Rus)
|
|
Nosov A.K., Mamizhev E.M., Shchekuteev N.A., Semeyko D.P., Lushina P.A., Rumyantseva D.I., Berkut M.V.
|
| Vol 18, No 4 (2022) |
Results of surgical treatment of malignant kidney tumors based on the materials of urology departments of the Siberian State Medical University clinics |
(Rus)
|
|
Latypov V.R., Popov V.S., Latypova V.N., Novikov S.I., Akhmedov D.B., Zebzeeva O.S.
|
| Vol 18, No 4 (2022) |
Study of the action of peripheral blood T-lymphocytes on renal cell carcinoma cells in model systems |
(Rus)
|
|
Kuzevanova A.Y., Khalmurzaev O.A., Borunova A.A., Apanovich N.V., Zabotina T.N., Alimov A.A., Matveev V.B., Karpukhin A.V.
|
| Vol 18, No 2 (2022) |
Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study |
(Rus)
|
|
Motzer R., Porta C., Alekseev B., Rha S.Y., Choueiri T.K., Mendez-Vidal M.J., Hong S.H., Kapoor A., Goh J.C., Eto M., Bennett L., Wang J., Pan J.J., Saretsky T.L., Perini R.F., He C.S., Mody K., Cella D.
|
| Vol 18, No 2 (2022) |
Situation with cancer care in Russia. Kidney cancer (median survival, cumulative survival, and survival of patients depending on their disease stage). Population-based study at the federal district level. Part 2 |
(Rus)
|
|
Merabishvili V.M., Nosov A.K.
|
| Vol 18, No 2 (2022) |
Prognostic significance of sPD-1/sPD-L1 in renal cancer depending on the phenotype of tumor and stromal cells |
(Rus)
|
|
Kovaleva O.V., Gratchev A.N., Makarova E.I., Bezhanova S.D., Stilidi I.S., Matveev V.B., Kushlinskii N.E.
|
| Vol 18, No 1 (2022) |
Review of the article “Laparoscopic partial nephrectomy: results of various surgery techniques” |
(Rus)
|
|
Perlin D.V.
|
| Vol 18, No 1 (2022) |
Laparoscopic partial nephrectomy: results of various surgery techniques |
(Rus)
|
|
Osetnik V.K., Orlova R.V., Gadzhiev N.K., Dzhalilov I.B., Rybalchenko V.A., Shkarupa D.D., Semenyakin I.V., Kuzmina I.N.
|
| Vol 18, No 1 (2022) |
Laparoscopic radical nephrectomy with inferior vena cava level I–III thrombectomy: experience of one center and literature review |
(Rus)
|
|
Nosov A.K., Mamizhev E.M., Aslanov B.I., Ryabinin R.I., Bayramov K.N., Rumyantseva D.I., Berkut M.V., Nekrasov D.V.
|
| Vol 17, No 4 (2021) |
Comparison of perioperative and short-term functional outcomes of laparoscopic partial nephrectomy in patients with cT1aN0M0 and cT1b-T2aN0M0 tumors |
(Rus)
|
|
Kotov S.V., Nemenov A.A., Yusufov A.G., Guspanov R.I., Pulbere S.A., Prostomolotov A.O.
|
| Vol 17, No 4 (2021) |
Long-term oncological results of surgical treatment of localized renal tumors |
(Rus)
|
|
Rakul S.A., Pozdnyakov K.V., Eloev R.A.
|
| Vol 17, No 4 (2021) |
Assessment of the state and relationship of vasopressor and renin-angiotensin systems in patients with localized kidney cancer on the background of arterial hypertension |
(Rus)
|
|
Osokin R.A., Aboyan I.A., Soldatkina N.V., Komarova E.F., Maksimov A.Y., Vlasov S.N.
|
| Vol 17, No 4 (2021) |
Similarities and differences in the process of metastasis and differentiation of renal cancer on gene expression |
(Rus)
|
|
Apanovich N.V., Matveev A.V., Apanovich P.V., Korotaeva A.A., Kipkeeva F.M., Muzaffarova T.A., Khalmurzaev O.A., Matveev V.B., Karpukhin A.V.
|
| Vol 17, No 4 (2021) |
Quality-adjusted time without symptoms or toxicity (Q-TWiST) for lenvatinib plus everolimus versus everolimus monotherapy in patients with advanced renal cell carcinoma |
(Rus)
|
|
Lee C.H., Wan Y., Smith A., Xie R., Motzer R.J.
|
| Vol 17, No 3 (2021) |
Experience of using 1st line combination immunotherapy in patients with metastatic renal cell carcinoma |
(Rus)
|
|
Kalpinskiy A.S., Myslevtsev I.V., Andrianov A.N., Nyushko K.M., Golovashchenko M.P., Vorobiev N.V., Chertkova Y.L., Shirukova I.K., Usanova E.Y., Alekseev B.Y.
|
| Vol 17, No 3 (2021) |
First experience of superselective embolization of renal arteries supplying the tumor with subsequent laparoscopic kidney resection |
(Rus)
|
|
Astashov V.L., Shapovalov V.V., Balanyuk V.V., Zagorul’ho A.I., Kozlov D.V., Andreeva M.A., Sinitsyna O.R., Radomskiy A.S.
|
| Vol 17, No 3 (2021) |
Review of the article "Prognosis of patients operated on for renal cell carcinoma and tumor venous thrombosis: experience of the Urology Clinics, N.N. Blokhin National Medical Research Center of Oncology" |
(Rus)
|
|
Karnaukh P.A.
|
| Vol 17, No 3 (2021) |
Review of the article "First experience of superselective embolization of renal arteries supplying the tumor with subsequent laparoscopic kidney resection" |
(Rus)
|
|
Perlin D.V.
|
| Vol 17, No 3 (2021) |
Prognosis of patients operated on for renal cell carcinoma and tumor venous thrombosis: experience of the Urology Clinics, N.N. Blokhin National Medical Research Center of Oncology |
(Rus)
|
|
Volkova M.I., Vashakmadze N.L., Klimov A.V., Begaliev A.K., Kuznetsov K.P., Matveev V.B.
|
| Vol 17, No 3 (2021) |
Long-term treatment outcomes of patients with non-clear cell renal cell carcinoma |
(Rus)
|
|
Mukhomedyarova A.A., Alekseev B.Y., Kalpinskiy A.S.
|
| Vol 17, No 2 (2021) |
Complications of robot-assisted and laparoscopic partial nephrectomy |
(Rus)
|
|
Rakul S.A., Pozdnyakov K.V., Eloev R.A.
|
| Vol 17, No 2 (2021) |
Review of the article “Technique and short-term outcomes of surgical treatment in patients with renal cell carcinoma and tumor venous thrombosis: experience of the Urology Clinic, N.N. Blokhin National Medical Research Center of Oncology” |
(Rus)
|
|
Карнаух П.А.
|
| Vol 17, No 2 (2021) |
Technique and short-term outcomes of surgical treatment in patients with renal cell carcinoma and tumor venous thrombosis: experience of the Urology Clinic, N.N. Blokhin National Medical Research Center of Oncology |
(Rus)
|
|
Matveev V.B., Volkova M.I., Vashakmadze N.L., Stilidi I.S.
|
| Vol 17, No 1 (2021) |
Nephrectomy and thrombectomy in renal cell carcinoma patients with extensive tumor venous thrombosis: how to minimize surgical risks? |
(Rus)
|
|
Matveev V.B., Stilidi I.S., Volkova M.I., Vashakmadze N.L., Klimov A.V., Begaliev A.K., Feoktistov P.I., Kuznetsov K.P., Davydov M.I.
|
| Vol 17, No 1 (2021) |
Efficacy and safety of lenvatinib and everolimus combination in patients with metastatic renal cell carcinoma progression following targeted antiangiogenic therapy: secondary analysis of data obtained in the Russian multicenter observational study |
(Rus)
|
|
Volkova M.I., Kalpinskiy A.S., Borisov P.S., Evsyukova O.I., Olshanskaya A.S., Matveev V.B., Alekseev B.Y., Peganova E.V., Nasretdinov A.F., Lymar E.V., Ovchinnikova E.G., Sveklina T.A., Usynin E.A., Abdelgafur A.M., Tararova E.A., Shumova L.M., Belenkov A.S., Dolgov I.Y., Ponomareva N.G., Evstigneeva I.V., Ivanov A.N., Isaev A.R., Leonenkov R.V., Meskikh A.V., Mukhitova M.R., Orlova S.A., Teslenok I.V., Shegurova M.M., Aivazov M.T., Amoev Z.V., Babina K.G., Vorontsova A.A., Karabina E.V., Kirdakova N.V., Shumskaya I.E., Kolesnikov G.P., Kuzmina E.S., Latipova D.K., Lyutova E.S., Fael M.M., Chugarova A.N., Antipin A.S.
|
| Vol 16, No 4 (2020) |
The R.E.N.A.L. nephrometry score in radiologist’s practice |
(Rus)
|
|
Rubtsova N.A., Kryaneva E.V., Golbits A.B., Alekseev B.Y., Kostin A.A., Kaprin А.D.
|
| Vol 16, No 4 (2020) |
Methylation of a group of microRNA genes: markers of renal cell carcinoma metastasis |
(Rus)
|
|
Apanovich N.V., Loginov V.I., Filippova E.A., Khodyrev D.S., Burdennyy A.M., Pronina I.V., Ivanova N.A., Lukina S.S., Kazubskaya T.P., Matveev V.B., Karpukhin A.V., Braga E.A.
|
| Vol 16, No 4 (2020) |
Clinical implication of kidney injury molecule (KIM-1) in blood plasma of renal-cell cancer patients |
(Rus)
|
|
Gershtein E.S., Naberezhnov D.S., Alferov A.A., Bezhanova S.D., Frolova N.F., Matveev V.B., Kuslinskii N.E.
|
| Vol 16, No 4 (2020) |
Review of the article “Clinical implication of kidney injury molecule (KIM-1) in blood plasma of renal-cell cancer patients” |
(Rus)
|
|
Vinarov A.Z.
|
| Vol 16, No 4 (2020) |
Review of the article “Resection of a kidney tumor with superselective targeted balloon-occluded chemoembolization” |
(Rus)
|
|
Popov A.M.
|
| Vol 16, No 4 (2020) |
Рекомендации по лечению пациентов с прогрессирующим или метастатическим почечно-клеточным раком комбинацией ленватиниба и эверолимуса |
(Rus)
|
|
Grande E., Glen H., Aller J., Argenziano G., Lamas M.J., Ruszniewski P., Zamorano J.L., Edmonds K., Sarker S., Staehler M., Larkin J.
|
| Vol 16, No 4 (2020) |
Resection of a kidney tumor with superselective targeted balloon-occluded chemoembolization |
(Rus)
|
|
Maksimov A.V., Martov A.G., Neustroev P.A., Alekseev V.A., Peretolchin D.V., Klarov L.A., Neustroev E.I., Kladkin N.P.
|
| Vol 16, No 3 (2020) |
Combination of pembrolizumab and axitinib: a new gold standard in the first-line therapy for metastatic clear-cell renal-cell carcinoma? |
(Rus)
|
|
Gafanov R.A., Dzidzaria A.G., Kravtsov I.B., Fastovets S.V.
|
| Vol 16, No 3 (2020) |
Combination of nivolumab and ipilimumab in the treatment of disseminated renal cell carcinoma. Realities and prospects |
(Rus)
|
|
Alekseev B.Y., Shevchuk I.M.
|
| Vol 16, No 3 (2020) |
The efficacy of lenvatinib plus everolimus in patients with metastatic renal cell carcinoma exhibiting primary resistance to front-line targeted therapy or immunotherapy |
(Rus)
|
|
Hamieh L., Beck R.L., Le V.H., Hsieh J.J.
|
| Vol 16, No 3 (2020) |
KIM-1 (kidney injury molecule 1) in the urine of renal cell carcinoma patients |
(Rus)
|
|
Kanukoev K.Y., Sergeeva N.S., Karmakova T.A., Marshutina N.V., Solokhina M.P., Nyushko K.M., Alekseev B.Y., Kaprin A.D.
|
| Vol 16, No 2 (2020) |
Laparoscopic thulium fiber laser partial nephrectomy without thermal ischemia |
(Rus)
|
|
Dubrovin V.N., Egoshin A.V., Tabakov A.V., Shakirov R.R., Mihaylovskiy O.V.
|
| Vol 16, No 2 (2020) |
Immunosuppressive peculiarities of stromal cells of various kidney tumor types |
(Rus)
|
|
Kovaleva O.V., Rashidova M.A., Samoilova D.V., Podlesnaya P.A., Tabiev R.M., Kuntsevich N.V., Efremov G.D., Alekseev B.Y., Gratchev A.N.
|
| Vol 16, No 2 (2020) |
Normotension — new approach in laparoscopic partial nephrectomy |
(Rus)
|
|
Dzhalilov I.B., Osetnik V.K., Mamizhev E.M., Parshina E.V., Krestyaninov S.S., Alekseev M.A., Orlova R.V.
|
| Vol 16, No 2 (2020) |
Review of the article “Normotension — new approach in laparoscopic partial nephrectomy” |
(Rus)
|
|
Perlin D.V.
|
| Vol 16, No 2 (2020) |
Comparative clinical and economic analysis of using cabozantinib as second-line therapy for adult patients with advanced renal cell carcinoma |
(Rus)
|
|
Krysanov I.S., Krysanova V.S., Alekseev B.Y., Ermakova V.Y., Gameeva E.V.
|
| Vol 16, No 1 (2020) |
Influence of surgical approach on enhanced recovery after surgery in laparoscopic radical nephrectomy |
(Rus)
|
|
Perlin D.V., Dymkov I.N., Davydova E.A., Shmanev A.O., Perlina A.V.
|
| Vol 16, No 1 (2020) |
Expression of growth factors and tyrosine kinase receptors in the primary tumor and tumor thrombus cells in patients with renal cell carcinoma |
(Rus)
|
|
Volkova M.I., Olshanskaya A.S., Tsimafeyeu I.V., Vashakmadze N.L., Khochenkova Y.A., Solomko E.S., Ashuba S.A., Khochenkov D.A., Matveev V.B.
|
| Vol 16, No 1 (2020) |
Tissue synthesis of some components of the renin-angiotensin system in hypertensive patients with localized kidney cancer |
(Rus)
|
|
Osokin R.A., Aboyan I.A., Komarova E.F., Maksimov A.Y., Komarova E.Y.
|
| Vol 15, No 4 (2019) |
Efficacy of incomplete metastasectomy in combination with targeted therapy in metastatic kidney cancer patients |
(Rus)
|
|
Borisov P.S., Orlova R.V., Shkolnik M.I., Karlov P.A., Topuzov E.E.
|
| Vol 15, No 4 (2019) |
Adrenal gland as a target of synchronous and metacronous metastasis from renal cell carcinoma: results of surgical treatment in a single institution |
(Rus)
|
|
Muradyan A.G., Kostin A.A., Vorobyev N.V., Tolkachev A.O.
|
| Vol 15, No 4 (2019) |
Is technically complicated partial nephrectomy justified in renal cell carcinoma patients with normal contralateral kidney? |
(Rus)
|
|
Volkova M.I., Ridin V.A., Cherniayev V.A., Klimov A.V., Figurin K.M., Kirichek A.A., Matveev V.B.
|
| Vol 15, No 4 (2019) |
Pancreatic metastases from renal cancer: comparing surgery and pharmacotherapy efficacy |
(Rus)
|
|
Kotelnikov A.G., Kriger A.G., Podluzhny D.V., Proskuryakov I.S., Galkin G.V., Patyutko Y.I., Fainstein I.A.
|
| Vol 15, No 3 (2019) |
Polymorphism of μ1-opioid receptor (OPRM1) gene may be of value in genesis of renal malignant neoplasm |
(Rus)
|
|
Potapov A.L., Kaprin A.D., Ivanov S.A., Boiarkina A.V., Novikov N.Y., Gevorkyan R.R., Kostyuk I.P.
|
| Vol 15, No 3 (2019) |
Fast track for partial nephrectomy |
(Rus)
|
|
Nosov A.K., Petrov S.B., Lushina P.A., Berkut M.V., Semenov A.V., Saad A.E.
|
| Vol 15, No 3 (2019) |
Review of the article “Polymorphism of μ1-opioid receptor (OPRM1) gene may be of value in genesis of renal malignant neoplasm” |
(Rus)
|
|
Karpukhin A.V.
|
| Vol 15, No 3 (2019) |
Efficacy and safety of lenvatinib in combination with everolimus in metastatic renal cell carcinoma resistant to antiangiogenic targeted therapy: Russian multicenter observational study ROSLERCM |
(Rus)
|
|
Volkova M.I., Abdelgafur A.M., Aivazov M.T., Amoev Z.V., Babina K.G., Borisov P.S., Vorontsovа A.A., Evstigneeva I.V., Evsyukova O.I., Zhelezin O.V., Kalpinsky A.S., Karabina E.V., Kirdakova N.V., Kolesnikov G.P., Kuzmina E.S., Latipova D.K., Leonenkov R.V., Maturov M.R., Meskikh A.V., Mishugin S.V., Ovchinnikova E.G., Olshanskaya A.S., Protsenko S.A., Semiglazova T.Y., Smirnov R.V., Usynin E.A., Fael M.M., Cherniakova E.M., Shumskaya I.E.
|
| Vol 15, No 2 (2019) |
Evaluation of quality of life of patients after surgical treatment of kidney cancer |
(Rus)
|
|
Popov S.V., Guseynov R.G., Orlov I.N., Skryabin O.N., Davydov A.V., Barkhitdinov R.S., Katunin A.S., Mirzabekov M.M.
|
| Vol 15, No 2 (2019) |
Capabilities of preoperative targeted therapy in treatment of bone metastases in renal cancer |
(Rus)
|
|
Yurmazov Z.A., Lushnikova N.A., Spirina L.V., Usynin E.A., Slonimskaya E.M., Anisenya I.I., Bogoutdinova A.V.
|
| Vol 15, No 1 (2019) |
Laparoscopic management renal cell carcinoma in left kidney with tumor caval thrombus |
(Rus)
|
|
Perlin D.V., Alexandrov I.V., Dymkov I.N., Shmanev A.O.
|
| Vol 15, No 1 (2019) |
Prognostic role of PBRM1 marker expression in clear-cell renal-cell carcinoma |
(Rus)
|
|
Zaridze D.G., Mazurenko N.N., Bezhanova S.D., Maksimovich D.M., Shangina O.V., Draudin-Krylenko V.A., Mukeria A.F., Matveev V.B.
|
| Vol 15, No 1 (2019) |
Kidney cancer mortality in Primorsky Krai |
(Rus)
|
|
Pisareva L.F., Alekseeva G.N., Lyakhova N.P., Doroshenko A.К., Cherdyntseva N.V., Choynzonov E.L.
|
| Vol 15, No 1 (2019) |
Comparative analysis of short-term results of retroperitoneoscopic and laparoscopic radical nephrectomy for large kidney tumors |
(Rus)
|
|
Kadyrov Z.A., Odilov A.Y., Yagudaev D.M.
|
| Vol 15, No 1 (2019) |
Review of the article “Laparoscopic management renal cell carcinoma in left kidney with tumor caval thrombus” |
(Rus)
|
|
Guliev B.G.
|
| Vol 15, No 1 (2019) |
Soluble forms of the immune check-point receptor PD-1 and its ligand PD-L1 in blood serum of patients with renal cell carcinoma: clinical and pathologic correlations |
(Rus)
|
|
Kushlinskii N.E., Gershtein E.S., Goryatcheva I.O., Morozov A.A., Alferov A.A., Bezhanova S.D., Kazantseva I.A., Bazaev V.V., Matveev V.B.
|
| Vol 14, No 4 (2018) |
Renal cell carcinoma: What’s new in 2018 |
(Rus)
|
|
Matveev V.B., Markova A.S.
|
| Vol 14, No 4 (2018) |
Therapeutic effects of pazopanib treatment in patients with metastatic kidney cancer in real clinical practice |
(Rus)
|
|
Berezin P.G., Milovanov V.V., Ivannikov A.A., Ognerubov N.A.
|
| Vol 14, No 4 (2018) |
Comparative analysis of intra- and postoperative complications of retroperitoneoscopic and laparoscopic nephrectomy for large tumors |
(Rus)
|
|
Kadyrov Z.A., Odilov A.Y., Yagudaev D.M.
|
| Vol 14, No 4 (2018) |
Safety of left renal vein ligation during circular resection of the inferior vena cava in right-side kidney carcinoma with tumor venous thrombosis |
(Rus)
|
|
Volkova M.I., Chernyaev V.A., Begaliev A.K., Klimov A.V., Matveev V.B.
|
| Vol 14, No 4 (2018) |
Review of the article “Comparative analysis of intra- and postoperative complications of retroperitoneoscopic and laparoscopic nephrectomy for large tumors” |
(Rus)
|
|
Perlin D.V.
|
| 1 - 100 of 259 Items |
1 2 3 > >>
|
